Protara Therapeutics Announces - GuruFocus.com
GuruFocus Article or News written by Stock market mentor and the topic is about:
Stay updated with breaking news from Jesse Shefferman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GuruFocus Article or News written by Stock market mentor and the topic is about:
Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical Officer NEW YORK, January 10, 2022 - Protara Therapeutics, Inc. , a clinical-stage company... | January 10, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic ... Protara TherapeuticsApril 23, 2021 GMT NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced a path forward related to TARA-002 for the treatment of Lymphatic Malformations (LMs), which are rare malformations of the lymph...
Provided by GlobeNewswire Apr 23, 2021 11:00 AM UTC NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced a path forward related to TARA-002 for the treatment of Lymphatic Malformations (LMs), which are rare malformations of the lymphatic vasculature for which there is no U.S. Food and Drug Administration (FDA)-approved treatment. Based on feedback from the FDA, the Company intends to com...
Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors February 02, 2021 08:00 ET | Source: Protara Therapeutics Protara Therapeutics New York, New York, UNITED STATES NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors. Ms. Smith brings to Protara over 20 years of diverse lead...